Sanofi/SAN

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX

About Sanofi

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Ticker

SAN

Sector

Healthcare

Trading on

PAR

Industry

Pharmaceuticals

CEO

-

Employees

86,088

Headquarters

Paris, France

Sanofi Metrics

BasicAdvanced
€108B
Market cap
23.91
P/E ratio
€3.61
EPS
0.45
Beta
€3.76
Dividend rate
4.35%
Dividend yield
€108B
0.45195
€3.76
24.778
14.39%
23.91
2.34
1.46
17.02
4.35%
0.19%
-45.64%
7.81%
-27.99%

What the Analysts think about Sanofi

Analyst Ratings

Majority rating from 27 analysts.
Buy

Sanofi Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.19% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€11B
-55.35%
Net income
€1.1B
-42.49%
Profit margin
10.19%
28.82%

Sanofi Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.34%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
€1.74
€2.55
€1.66
€1.78
-
Expected
€1.67
€2.58
€1.68
€1.72
€1.57
Surprise
4.31%
-1.34%
-1.44%
3.34%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Euronext. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Sanofi stock?

Sanofi (SAN) has a market cap of €108B as of June 17, 2024.

What is the P/E ratio for Sanofi stock?

The price to earnings (P/E) ratio for Sanofi (SAN) stock is 23.91 as of June 17, 2024.

Does Sanofi stock pay dividends?

Yes, the Sanofi (SAN) stock pays dividends to shareholders. As of June 17, 2024, the dividend rate is €3.75999 and the yield is 4.35%. Sanofi has a payout ratio of 0% on a trailing twelve-month basis.

When is the next Sanofi dividend payment date?

The next Sanofi (SAN) dividend payment date is unconfirmed.

What is the beta indicator for Sanofi?

Sanofi (SAN) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Sanofi stock price target?

The target price for Sanofi (SAN) stock is €106.64, which is NaN% below the current price of €. This is an average based on projections from 25 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Sanofi stock

Buy or sell Sanofi stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing